Who (what) pays toll for the development of herpetic stromal keratitis (HSK)

Seminars in Ophthalmology

Volumn 23, Issue 4, 2008, Pages 229-234

  Hayashi, Kozaburo ^a   Hooper, Laura C ^a   Hooks, John J ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

HSK; HSV IgG immune complex; HSVDNA; IL 6; MMP 9; Toll like receptor (TLR 3, 9); VEGF

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN G; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; VASCULOTROPIN; VIRUS DNA;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; AUTOIMMUNITY; CORNEA CELL; CORNEA NEOVASCULARIZATION; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPETIC STROMAL KERATITIS; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOPATHOGENESIS; MACROPHAGE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; CORNEAL STROMA; DNA, VIRAL; HUMANS; IMMUNOGLOBULIN G; KERATITIS, HERPETIC; SIMPLEXVIRUS; TOLL-LIKE RECEPTORS;

EID: 46349107103     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530802111408     Document Type: Review

References (70)

1. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 2003; 85:85-95.
2. Araki-Sasaki K, Tanaka T, Ebisuno Y, Kanda H, Umemoto E, Hayashi K, Miyasaka M. Dynamic expression of chemokines and infiltration of inflammatory cells in the HSV-infected cornea and its associated tissue. Ocular Immunol. Inflamm. 2006; 14:257-266.
3. Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol. 1995; 154:4822-4829.
4. Babu JS, Thomas J, Kanangat S, Morrison IA, Knipe DM, Rouse BT. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 1996; 70:101-107.
5. Biswas PS, Rouse BT. Early events in HSV keratitis-setting the stage for a blinding disease. Microb. Infect. 2005; 7:799-810.
6. Biswas PS, Benerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res. 2006; 82:46-54.
7. Cesario TG, Poland JD, Wulff H, Chin TY, Wenner HA. Six years experience with herpes simplex virus in a children's home. Am J Epidemiol 1969;90:416-422.
8. Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp. Eye Res 1998a; 67:619-624.
9. Daheshia M, Kuklin N, Manickan E, Chun S, Rouse BT. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine 1998b; 16:1103-1110.
10. Darougar S, Wishart MS, Viswalingam ND. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Brit. J Ophthalmol 1985; 69:2-6.
11. Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopatrhogenesis and therapeutic measure. Expert. Rev. Mol. Med. 2004;1-14.
12. Doymaz MZ, Rouse BT. Immunopathology of herpes simplex virus infections. Curr Top Microbiol Immunol 1992; 179:121-136.
13. Duan R, Remeijer L, vanDun JM, Osterhaus ADME, Verjans GMGM. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest. Ophthalmol. Vis. Sci. 2007; 48:277-284.
14. Easty DL, Shimeld C, Claoue CM, Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr. Eye Res. 1987; 6:69-74.
15. Enquist LW, Husak PJ, Banfield BW, Smith GA. Infection and spread of aqlphaherpesviruses in the nervous system. Adv. Virus Res. 1998; 51:237-347.
16. Fraser NW, Valyi-Nagy T. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb. Pathog. 1993; 15:83-91.
17. Fukuda M, Deai T, Hibino T, Higaki S, Hayashi K, Shimomura Y. Quantitative analysis of herpes simplex virus genomes in tears from patients with herpetic keratits. Cornea 2003; 22(suppl 1):555-560.
18. Hayashi K, Hooper LC, Chin MS, Nagineni CN , Detrick B, Hooks JJ. Herpes simplex virus 1 (HSV-1)DNA and immune complex (HSV-1 -human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 2006; 87:2161-2169.
19. Herbst-Kralovetz M, Pyles R. Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 2006;13:37-41.
20. Hui J, Zhang J, Kumar A, Zheng M, Atherton SS, Yu FSX. Herpes simplex virus 1 infection induces expression of proinflammatory cytokines, interferons and TLR 7 in human corneal epithelial cells. Immunology 2005; 117:167-176.
21. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004; 5:987-995.
22. Jin X, Qin Q, Chen W, Qu J. Expression of Toll-like receptors in the healthy and herpes simplex virus-infected cornea. Cornea 2007; 26:847-852.
23. Kanangat S, Babu JS, Knipe DM, Rouse BT. HSV-1 mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology 1996; 219:295-300.
24. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest. Ophthalmol. Vis. Sci. 2005; 46:241-247.
25. Kaye SB, Baker E, Bonshek R, Maseruka H, Grinfeld E, Tullo A, Easty D, Hart C. Human herpes viruses in the cornea. Brit. J Ophthalmol 2000; 84:563-571.
26. Kim B, Suvas S, Sarangi PP, Lee S, Reisfeld RA, Rouse BT. Vascular endothelial growth factor receptor 2- based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. J Immunol 2006; 177:4122-4131.
27. Kimberlin DW. Neonatal herpes simplex infection. Clin. Microb. Rev. 2004; 17:1-13.
28. Knotts FB, Cook ML, Stevens JG. Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J Infect Dis. 1974; 130:16-24.
29. Koelle DM, Reymond SN, Chen H, Kwok WW, McClurkan C, Gyaltsong T, Petersdorf EW, Rotkins W, Talley AR, Harrison DA. Tegment-specific, virus-reactive CD4T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J Virol 2000; 74:10930-10938.
30. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004; 103:1433-1437.
31. Kumaraguru U, Davis I Rouse BT. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus. J Neuro Virol 1999; 5:42-47.
32. Kumarugaru U, Rouse BT. The IL-12 response to herpes simplex virus is mainly a paracrine response of reactive inflammatory cells. J Leukoc Biol 2002; 71:564-570.
33. Kurt-Jones EA, Chan M, Zhou S, Wang JU, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101:1315-1320.
34. Kwong AD, Kruper JA, Frenkel N. Herpes simplex virus virion host shutoff function. J Virol. 1988; 62:912-921.
35. Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 2002; 110:1105-1111.
36. Liesengang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001; 20:1-13.
37. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198:513-520.
38. Lundberg P, Welander P, Han X, Cantin E. Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 2003; 77:11158-11169.
39. Macrtzdorf J, Osterhaus ADME, Verjans GMGM. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol. 2002; 169:5897-5903.
40. Maggs DJ, Chang E, Nasisse MP, Mitchell WJ. Persistence of herpes simplex virus type1 DNA in chronic conjunctival and eyelid lesions of mice. J Virol 1998; 72:9166-9172.
41. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. Establishment of monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 2002; 293:1364-1369.
42. Mercadal CM, Bouley DM, DeStephano D, Rouse BT. Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol 1993; 67:3404-3408.
43. Metcalf JF, Hamilton DS, Reichert RW. Herpetic keratitis in athymic (nude) mice. Infect Immun 1979; 26:1164-1171.
44. Meyers RL, Chitjian PA. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections. Surv. Ophthalmol. 1976; 21:194-204.
45. Meyers-Elliott RH, Chitjian PA, Dithiefs BA. Experimental herpesvirus keratits in the rabbit: topical versus intrastromal infection route. Ophthalmic Res. 1983; 15:240-256.
46. Meyers-Elliott RH, Petit TH, Maxwell WA. Viral antigens in the immune ring of Herpes simplex stromal keratitis. Arch Ophthalmol 1980; 98:897-904.
47. Miller JK, Laycock KA, Nash MM, Pepose JS. Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest Ophthalmol Vis Sci 1993;34:2282-2290.
48. Mitchell W, Gressens JP, Martin JR, DeSanto R. Herpes simplex virus type1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J. Gen Virol 1994; 75:1201-1210.
49. Pepose JS, Leib DA, Stuart M, Easty D. Herpes simplex virus disease: anterior segment of the eye. In Pepose JS, Holland GN, Wilhelmus KR (eds.), Ocular Infection and Immunity, pp. 905-932, Mosby, St. Louis, 1996.
50. Shimeld C, Hill TJ, Blyth B, Easty D. Improved model of recurrent herpetic eye disease in mice. Curr. Eye Res. 1989; 8:1193-1205.
51. Shimomura Y, Deai T, Fukuda M, Higaki S, Hoopre LC, Hayashi K. Corneal buttons obtained from patients with HSK harbor high copy number of the HSV genome. Cornea 2007; 26:190-193.
52. Streilein WJ, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratits. Immunol Today 1997; 18:443-449.
53. Su YH, Yan XT, Oakes JE, Lausch RN. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type1 corneal infection. J Virol 1996; 70:1277-1281.
54. Suvas S, Azkur AK, Kim BS, Kumagaru U, Rouse BT. CD4+ CD25+ regulatory T cells control the severity of viral immunoimnflammatory lesions. J Immunol. 2004; 172:4123-4132.
55. Taddeo B, Roizman B. The virion host shutoff (UL41) protein of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase A. J Virol. 2006; 80:9341-9345.
56. Takada K, Kaisho T, Akira S. Toll-like receptors. Ann. Rev Immunol. 2003; 21:335-376.
57. Thomas J, Rouse BT. Immunopathogenesis of herpetic ocular disease. Immunol. Res. 1997; 16:375-386.
58. Thomas J, Kanangat S, Rouse BT. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res. 1998; 18:681-690.
59. Tran MT, Dean DA, Lausch RN, Oakes JE. Members of herpes simplex type-1 infected human corneal epithelial cells are not permiabilized to macromolecules and therefore do not release IL-1 alpha. Virology 1998; 244:74-78.
60. Tullo AB, Schimeld C, Blyth WA, Hill TJ, Easty DL. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J Gen Virol 1982; 63:95-101.
61. Tullo AB, Shimeld C, Blyth WA, Hill TJ, Easty DL, Ocular infection with herpes simplex virus in nonimmyne and immune mice. Arch. Ophthalmol. 1983; 101:961-965.
62. Ueta M, Hamuro J, Kiyono H, Kinoshita S. Triggering of TLR-3 by poly I:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys. Res. Comm. 2005; 331:285-294.
63. Verjans GM, Remeijer L, van Binnendijik RS, Cornelissen JG, Volker-Dieben HJ, Baarsma SG, Osterhaus AD. Identification and characterization of herpes simplex virus-specific CD4 + T cells in corneas of herpetic stromal keratitis patients. J Infect. Dis. 1998; 73:484-488.
64. Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Barron BA, Kaufman HE, Sugar J, Hyndiuk RA. Herpetic Eye Study: a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101:1883-1895.
65. Youinou P, Colin I, Mottier D. Immunological analysis of the cornea in herpetic stromal keratitis. J Clin Lab Immunol 1985; 17:105-106.
66. Youinou P, Colin J, Ferec C. Monoclonal antibody analysis of blood and cornea T lymphocyte subpopulations in herpes simplex keratitis. Graefes Arch. Clin. Exp. Ophthalmol 1986; 224:131-133.
67. Whitley RJ, Kimberlin DW. Herpoes simplex: Encephalitis children and adolescents. Semin. Ped. Inf. Dis. 2005; 16:17-23.
68. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303:1522-1526.
69. Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis ofherpetic stromal keratitis. J Virol 2001a; 75:9828-9835.
70. Zheng M, Schwarz MA, Lee S, Kumaraguru U, Rouse BT. Control of stromal keratitis by inhibition of neovascularization. Am J Pathol 2001b; 159:1021-1029.